| The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth S Di Somma, CA Iannuzzi, C Passaro, IM Forte, R Iannone, V Gigantino, ... Frontiers in oncology 9, 564, 2019 | 52 | 2019 |
| Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma D Di Marzo, IM Forte, P Indovina, E Di Gennaro, V Rizzo, F Giorgi, ... Cell Cycle 13 (4), 652-665, 2014 | 40 | 2014 |
| Virotherapy: From single agents to combinatorial treatments AM Malfitano, S Di Somma, CA Iannuzzi, F Pentimalli, G Portella Biochemical pharmacology 177, 113986, 2020 | 39 | 2020 |
| Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide IM Forte, P Indovina, CA Iannuzzi, D Cirillo, D Di Marzo, D Barone, ... International journal of oncology 54 (6), 2189-2199, 2019 | 35 | 2019 |
| P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma C Costa, P Indovina, E Mattioli, IM Forte, CA Iannuzzi, L Luzzi, C Bellan, ... Cell Death & Disease 11 (9), 748, 2020 | 32 | 2020 |
| RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines F Pentimalli, IM Forte, L Esposito, P Indovina, CA Iannuzzi, L Alfano, ... Oncogene 37 (27), 3657-3671, 2018 | 27 | 2018 |
| LPS-induced inflammatory response triggers cell cycle reactivation in murine neuronal cells through retinoblastoma proteins induction B D'Angelo, C Astarita, S Boffo, M Massaro-Giordano, C Antonella Ianuzzi, ... Cell Cycle 16 (24), 2330-2336, 2017 | 22 | 2017 |
| SRC family kinase inhibition in Ewing sarcoma cells induces p38 MAP kinase‐mediated cytotoxicity and reduces cell migration P Indovina, N Casini, IM Forte, T Garofano, D Cesari, CA Iannuzzi, ... Journal of cellular physiology 232 (1), 129-135, 2017 | 19 | 2017 |
| Triple-negative breast cancer comparison with canine mammary tumors from light microscopy to molecular pathology AA Namagerdi, D d’Angelo, F Ciani, CA Iannuzzi, F Napolitano, ... Frontiers in Oncology 10, 2020 | 15 | 2020 |
| Blood screening for heavy metals and organic pollutants in cancer patients exposed to toxic waste in southern Italy: A pilot study IM Forte, P Indovina, A Costa, CA Iannuzzi, L Costanzo, A Marfella, ... Journal of Cellular Physiology 235 (6), 5213-5222, 2020 | 14 | 2020 |
| Triple-negative breast cancer comparison with canine mammary tumors from light microscopy to molecular pathology A Amirkhani Namagerdi, D d’Angelo, F Ciani, CA Iannuzzi, F Napolitano, ... Frontiers in Oncology 10, 563779, 2020 | 12 | 2020 |
| p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab P Vici, F Sperati, M Maugeri-Saccà, E Melucci, A Di Benedetto, L Di Lauro, ... Oncotarget 5 (21), 10382, 2014 | 12 | 2014 |
| NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer L Alfano, A Caporaso, A Altieri, C Costa, IM Forte, CA Iannuzzi, D Barone, ... Journal of Cellular Physiology 233 (5), 4338-4344, 2018 | 11 | 2018 |
| The oncolytic caprine herpesvirus 1 (CpHV-1) induces apoptosis and synergizes with cisplatin in mesothelioma cell lines: a new potential virotherapy approach IM Forte, P Indovina, S Montagnaro, A Costa, CA Iannuzzi, F Capone, ... Viruses 13 (12), 2458, 2021 | 10 | 2021 |
| RBL1/p107 expression levels are modulated by multiple signaling pathways E Ventura, CA Iannuzzi, F Pentimalli, A Giordano, A Morrione Cancers 13 (19), 5025, 2021 | 6 | 2021 |
| Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines CA Iannuzzi, P Indovina, IM Forte, S Di Somma, AM Malfitano, M Bruno, ... International journal of molecular sciences 21 (19), 7333, 2020 | 5 | 2020 |
| Abstract lb-080: reactivating rbl2/p130 oncosuppressive function as a new, possible antitumoral strategy F Pentimalli, L Esposito, IM Forte, CA Iannuzzi, F Rizzolio, T Tuccinardi, ... Cancer Research 75 (15_Supplement), LB-080-LB-080, 2015 | 2 | 2015 |
| Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma C Costa, P Indovina, E Mattioli, IM Forte, CA Iannuzzi, L Luzzi, C Bellan, ... Cell Death & Disease 11 (10), 2020 | 1 | 2020 |
| Oncolytic viruses as a possible therapeutic strategy against malignant mesothelioma CA Iannuzzi, C Passaro, S Boffo, IM Forte, P Indovina, M Macaluso, ... Cancer Research 76 (14_Supplement), 3747-3747, 2016 | 1 | 2016 |
| CDK9-55 guides the anaphase-promoting complex/cyclosome (APC/C) in choosing the DNA repair pathway choice L Alfano, CA Iannuzzi, D Barone, IM Forte, MC Ragosta, M Cuomo, ... Oncogene 43 (17), 1263-1273, 2024 | | 2024 |
